Epivizor ApS
Private limited companyCVR 39999943SilkeborgActive
Epivizor ApS is a private limited company, based in Silkeborg, active in research and experimental development on natural sciences and engineering, founded in 2018. Net profit rose 52% from 2024 to 2025, ending at DKK 49,804. Profit has grown three years in a row. Equity grew to DKK 302k in 2025.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- Net profit rose 52% (2024 → 2025), to DKK 49,804.
- Equity rose 20% (2024 → 2025), to DKK 302k.
Registrations, last 24 months
- 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2020–2025 · amounts in DKK thousandEquity and net profit
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | not stated | not stated | not stated | – |
| Gross profit | 301 | −25 | −9 | −13 | −15 | −4 | +75.2% |
| Operating profit (EBIT) | 251 | −25 | −9 | −13 | −15 | −4 | +75.2% |
| Profit before tax | 265 | 20 | −130 | 22 | 42 | 50 | +18.7% |
| Net profit | 207 | 19 | −102 | 17 | 33 | 50 | +51.8% |
| Total assets | 517 | 510 | 411 | 436 | 469 | 519 | +10.6% |
| Equity | 286 | 305 | 203 | 219 | 252 | 302 | +19.7% |
| Liabilities | 231 | 205 | 208 | 217 | 217 | 217 | 0% |
| Cash and cash equivalents | 193 | 20 | 11 | 10 | 2 | 15 | +541.9% |
| Average number of employees | 2 | – | – | – | 0 | 0 | – |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Annual reports
6 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 26/06/2026 | The company | PDF not statedXBRL |
| 2024 | 01/01/2024 – 31/12/2024 | 03/07/2025 | The company | PDF not statedXBRL |
| 2023 | 01/01/2023 – 31/12/2023 | 15/06/2024 | The company | PDF not statedXBRL |
| 2022 | 01/01/2022 – 31/12/2022 | 17/06/2023 | The company | PDF not statedXBRL |
| 2021 | 01/01/2021 – 31/12/2021 | 01/06/2022 | The company | PDF not statedXBRL |
| 2020 | 01/01/2020 – 31/12/2020 | 17/03/2021 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Position in the industry
431 companies in the databaseComparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.
Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 63,229of 69,742 Better than 9% | No. 47,201of 69,964 Better than 33% |
| Same industry and fewer than 20 employees329 companies in the comparison | No. 178of 323 Better than 45% | No. 185of 329 Better than 44% |
| Companies that are between 5 and 14 years old33,688 companies in the comparison | No. 31,204of 33,588 Better than 7% | No. 22,446of 33,687 Better than 33% |
| All companies of type ApS66,508 companies in the comparison | No. 60,777of 66,379 Better than 8% | No. 43,174of 66,505 Better than 35% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Research and experimental development on natural sciences and engineering- Epivizor ApS−DKK 3,604
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Epivizor ApSDKK 49,804
- Carlsberg A/SDKK 7bn
- Zealand Pharma A/SDKK 6.5bn
- Epivizor ApSDKK 302k
- Carlsberg A/SDKK 30.7bn
- Zealand Pharma A/SDKK 14.8bn
- Epivizor ApS3
- Carlsberg A/S107
- Zealand Pharma A/S569
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- KADEL Holding ApS50%
- JMSU Holding ApS50%
Management
2 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Jens Munch Sundbøll | Director | 02/11/2018 |
| Kasper Adelborg | Director | 02/11/2018 |
- Founders
- KADEL Holding ApS, JMSU Holding ApS
Signing rule: Selskabet tegnes af to direktører i forening.
Address and production units
1 active production unitsLangdalsparken 19
8600 Silkeborg
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Epivizor ApS | Langdalsparken 19, Sejs-Svejbæk, 8600 Silkeborg | 3 | 1024105578 |
Purpose
Selskabets formål er at drive forsknings- og konsulentvirksomhed indenfor det sundhedsvidenskabelige område, samt al virksomhed, der efter direktionens skøn er beslægtet hermed.
The purpose is quoted from the register in Danish.
Changes year by year
14 registered events20261 changeaccounts 1
- AccountsAnnual report for 2025 published
20252 changesaccounts 1 · industry 1
- AccountsAnnual report for 2024 published
- IndustryIndustry changed to Research and experimental development on natural sciences and engineering (721000)
20241 changeaccounts 1
- AccountsAnnual report for 2023 published
20231 changeaccounts 1
- AccountsAnnual report for 2022 published
20221 changeaccounts 1
- AccountsAnnual report for 2021 published
20211 changeaccounts 1
- AccountsAnnual report for 2020 published
20202 changesname 1 · capital 1
- NameName changed from Epivizor IVS to Epivizor ApS
- CapitalShare capital changed from 2 DKK to 40,000 DKK
20185 changesfounded 1 · management 2 · ownership 2
- FoundedRegistered as Epivizor IVS
- ManagementJens Munch Sundbøll appointed director
- ManagementKasper Adelborg appointed director
- OwnershipKADEL Holding ApS registered as owner (50%)
- OwnershipJMSU Holding ApS registered as owner (50%)
Related companies
Largest in the industry
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Gubra A/SDKK 2.6bn
- Vestas Wind Systems A/SDKK 2.5bn
- Bang & Olufsen A/SDKK 1.4bn
- 3shape A/SDKK 1.3bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026.